UMIN-CTR Clinical Trial

Basic information
Public title	Study about the treatment for glaucoma
Acronym	Study about the treatment for glaucoma
Scientific Title	Study about the treatment for glaucoma
Scientific Title:Acronym	Study about the treatment for glaucoma
Region	Japan

Condition
Condition	glaucoma
Classification by specialty	Ophthalmology
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Analysis of the treatment for glaucoma
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Outcome of the treatment for glaucoma
Key secondary outcomes

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	18 years-old <=
Age-upper limit	100 years-old >=
Gender	Male and Female
Key inclusion criteria	patients with glaucoma
Key exclusion criteria	age younger than 17 years old or older than 100 years old
Target sample size	10000

Research contact person
Name of lead principal investigator	1st name Asaoka Middle name Last name Ryo
Organization	Seirei Hamamatsu General Hospital
Division name	Ophthalmology
Zip code	432-8068
Address	2-12-12 Sumiyoshi, Naka-ku, Hamamatsu City, Shizuoka, Japan
TEL	0534742222
Email	rasaoka-tky@umin.ac.jp

Public contact
Name of contact person	1st name Asaoka Middle name Last name Ryo
Organization	Seirei Hamamatsu General Hospital
Division name	Ophthalmology
Zip code	432-8068
Address	2-12-12 Sumiyoshi, Naka-ku, Hamamatsu City, Shizuoka, Japan
TEL	0534742222
Homepage URL
Email	rasaoka-tky@umin.ac.jp

Sponsor
Institute	Seirei Hamamatsu General Hospital, Department of Ophthalmology, Ryo Asaoka
Institute
Department

Funding Source
Organization	MEXT
Organization
Division
Category of Funding Organization	Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Ethics committee of Seirei Hamamatsu Genearl Hospital
Address	2-12-12 Sumiyoshi, Naka-ku, Hamamatsu City, Shizuoka, Japan
Tel	0534742222
Email	m-kimata@sis.seirei.or.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2022 Year 10 Month 20 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Enrolling by invitation
Date of protocol fixation	2022 Year 10 Month 20 Day
Date of IRB	2022 Year 08 Month 17 Day
Anticipated trial start date	2022 Year 10 Month 20 Day
Last follow-up date	2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	None

Management information
Registered date	2022 Year 10 Month 20 Day
Last modified on	2022 Year 10 Month 20 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056107